Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sodium Glucose Cotransporter Inhibitors on Fatty Liver Disease Patients

NCT05694923 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05694923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05694923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sodium Glucose Cotransporter Inhibitors on Fatty Liver Disease Patients
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2023
Completion date
April 1, 2024
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver disease